Insights
Therapeutic strategies for ovarian cancer and the use of biomarkers for monitoring prognosis
Over the last decades, biomarkers have become an extremely important tool in the care of patients with ovarian cancer. Biomarkers are capable of...
Scientific poster - Analytical performance of the Lumipulse® G NfL CSF <RUO>
Poster presented at the AD/PD 2023
This AD/PD 2023 poster wishes to demonstrate the analytical performance of the newly developed Lumipulse G NfL CSF...
Scientific poster - Comparing CSF and plasma LUMIPULSE® Alzheimer’s Disease biomarker analysis to amyloid-β PET imaging
The aim of this study was to evaluate a plasma pTau biomarker as a tool for predicting amyloid pathology.
Webinar: First void urine & HPV genotyping - Two essential tools to monitor the impact of HPV vaccination programs
The enormous potential of a first void – or initial stream – urine sample becomes evident when we understand it’s composition. In fact, in the case of...
Japanese authorities have chosen Lumipulse® for nasopharyngeal or saliva-based SARS-CoV-2 antigen testing of passengers at their main international airports
Several fully automated and CLEIA-based LUMIPULSE G1200 systems from Fujirebio are right now performing fast, high sensitivity SARS CoV-2 antigen...
An overview of ovarian cancer: the development of biomarkers for early detection
It has been estimated that in 2020, about 21,750 women in the US will receive a new ovarian cancer diagnosis and about 13,940 women will die from this...
Interview: Urine self sampling could change the world of testing, not only for HPV but also for other oncology markers
Our own Rebecca Millecamps, Marketing Manager at Fujirebio, was interviewed for the podcast series 'Molecules, microbes and multiomics' about the...
Influence of automation on Aβ1-42/Aβ1-40 ratio and its use
Automation is an important step in the direction of more standardization as it limits the number of manual handling steps and therefore minimizes...
Comparison of Aβ1-42/Aβ1-40 ratio with other ratios
CSF Aβ1-42/Aβ1-40 is a tool to normalize values of patients with different amyloid levels, as other ratios might be seen more as interpretation tools...